So I wrote a little thing for @MolMetab sciencedirect.com/science/articl As we now appreciate, GLP-1 can target multiple brain regions and neuronal populations to reduce food intake, and the clinical results are increasingly impressive #obesity The ongoing SELECT trial will be pivotal for the field sciencedirect.com/science/articl From very modest weight loss with exenatide twice daily, the GLP-1 field has learned, by titration, dose escalation, higher Cmax, and better molecules, to achieve clinically meaningful #weightloss #T2D #obesity More progress to come #obesity described here sciencedirect.com/science/articl Beyond semaglutide and tirzepatide, where might we find the next GLP-1-based advances in #weightloss #obesity Take a look at the slope of the lines for the combination of cagrilintide + semaglutide and make projections out to 52 weeks thelancet.com/journals/lance Join the conversation
10.1016/j.lfs.2011.01.015 49 IlicS.DrmicD.ZarkovicK.KolencD.BrcicL.RadicB.et al (2011b)
This allows researchers to receive a stable peptide preparation suitable for long-term storage and controlled reconstitution procedures
Functional pathway analysis of GHK-Cu-responsive genes reveals enrichment in processes fundamental to tissue regeneration and homeostasis
The BioTE supplement BPC-157 (body protection compound) is a proprietary combination of 15 amino acids that repairs muscles, tendons and soft tissues
(2023) 67:e2200884